Depression • MindMed

Now Enrolling
Written By Kirsten Hirst

MM311

About the Study

This study is designed to evaluate the efficacy of a single dose of 100 µg of MM-120 (D-lysergic acid diethylamide D-tartrate), versus placebo, for the treatment of depression symptoms.

This study is sponsored by Mind Medicine, Inc.

Eligibility

You may be eligible to participate in this study if you:

  • are between the ages of 18 – 74 years old

  • meet DSM-5 criteria for Major Depressive Disorder (MDD)

  • are currently experience symptoms of depression

  • can spend the day at our facility for an 8-hour dosing session (up to 12-hours if needed)

Apply Today

If you are interested in participating in this clinical trial, please call our friendly staff at 801-871-5516 today. You can also fill out the contact form below.

 

View our Privacy Policy and Terms and Conditions.

Kirsten Hirst
Next

Depression • Cybin